Potential role of mesenchymal stromal cells in pediatric hematopoietic SCT (original) (raw)

• Fibbe WE, Lazarus HM . Mesenchynmal stem cells and hematopoietic stem cell transplantation. In: Atkinson K, Champlin R, Brenner MA, Fibbe WE, Ritz J, Ljungman P (eds), 3rd edn. Clinical Bone Marrow and Blood Stem Cell Transplantation. Cambridge University Press, UK, 2004, pp 67–78.
  Google Scholar
• Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, Ruadkow IA . Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 1974; 2: 83–92.
  CAS PubMed Google Scholar
• Owen M . Marrow stromal stem cells. J Cell Sci 1988; 10 (Suppl): 63–76.
  Article CAS Google Scholar
• Prockop DJ . Marrow stromal cells as stem cells for non-hematopoietic tissues. Science 1997; 276: 71–74.
  Article CAS Google Scholar
• Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL . Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol 1998; 176: 57–66.
  Article CAS Google Scholar
• Almeida-Porada G, Flake AW, Glimp HA, Zanjani ED . Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol 1999; 27: 1569–1575.
  Article CAS Google Scholar
• In ‘t Anker PS, Noort WA, Kruisselbrink AB, Scherjon SA, Beekhuizen W, Willemze R et al. Non expanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 2003; 31: 881–889.
  Article Google Scholar
• Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393–395.
  Article CAS Google Scholar
• Nathanson MA . Bone matrix-directed chondrogenesis of muscle in vitro. Clin Orthop 1985; 200: 142–158.
  CAS Google Scholar
• Nakahara H, Dennis JE, Bruder SP, Haynesworth SE, Lennon DP, Caplan AI . In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res 1991; 195: 492–503.
  Article CAS Google Scholar
• Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM . Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98: 2396–2402.
  Article CAS Google Scholar
• Fernandez M, Simon V, Herrera G, Cao C, Del Favero H, Minguell JJ . Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant 1997; 20: 265–271.
  Article CAS Google Scholar
• Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI . Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995; 16: 557–564.
  CAS PubMed Google Scholar
• Erices A, Conget P, Minguell JJ . Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 2000; 109: 235–242.
  Article CAS Google Scholar
• Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, Fagioli F . Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 2001; 86: 1099–1100.
  CAS PubMed Google Scholar
• In ‘t Anker PS, Scherjon SA, Kleijburg-Van Der Keur C, Noort WA, Claas FH, Willemze R et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003; 102: 1548–1549.
  Article Google Scholar
• Battula VL, Treml S, Abele H, Bühring HJ . Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody. Differentiation 2008; 76: 326–336.
  Article CAS Google Scholar
• Banfi A, Bianchi G, Notaro R, Luzzatto L, Cancedda R, Quarto R . Replicative aging and gene expression in long-term cultures of human bone marrow stromal cells. Tissue Eng 2002; 8: 901–910.
  Article CAS Google Scholar
• Vogel JP, Szalay K, Geiger F, Kramer M, Richter W, Kasten P . Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets 2006; 17: 462–469.
  Article CAS Google Scholar
• Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838–3843.
  Article CAS Google Scholar
• Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F . Bone marrow mesenchymal stem cells inhibit the response of naïve and memory antigen-specific T-cells to their cognate peptide. Blood 2004; 101: 3722–3729.
  Article Google Scholar
• Aggarwal S, Pittenger MF . Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815–1822.
  Article CAS Google Scholar
• Sotiropoulou PA, Perz SA, Gritzapis AD, Baxevanis CN, Papmichail M . Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 2006; 24: 74–85.
  Article Google Scholar
• Nauta AJ, Westerhuis G, Kruisselbrink AB, Lurvink EG, Willemze R, Fibbe WE . Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 2006; 108: 2114–2120.
  Article CAS Google Scholar
• Nauta AJ, Fibbe WE . Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499–3506.
  Article CAS Google Scholar
• Meisel R, Ziber A, Laryea M, Göbel U, Däubener W, Dilloo D . Human bone marrow stromal cells inhibit allogeneic responses by indoleamine 2,3 dioxygenase mediated tryptophan degradation. Blood 2004; 103: 4619–4621.
  Article CAS Google Scholar
• Rasmusson I, Ringden O, Sundberg B, Le Blanc K . Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003; 76: 1208–1213.
  Article Google Scholar
• Almeida-Porada G, Porada CD, Tran N, Zanjani ED . Co-transplantation of human stromal cell progenitors into pre-immune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000; 95: 3620–3627.
  CAS PubMed Google Scholar
• Devine SM, Bartholomew AM, Mahmud N, Nelson M, Patil S, Hardy W, Sturgeon C et al. Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion. Exp Hematol 2001; 29: 244–255.
  Article CAS Google Scholar
• Noort WA, Kruisselbrink AB, de Paus RA, Kruger M, van Bezooijen RL, de Paus RA et al. Co-transplantation of mesenchymal stem cells (MSCs) and UCB CD34+ cells results in enhanced hematopoietic engraftment in NOD/SCID mice without homing. Exp Hematol 2002; 30: 870–878.
  Article Google Scholar
• Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42–48.
  Article Google Scholar
• Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramírez M, Bueren JA . Adipose tissue-derived mesenchymal stem cells (AD-MSC) have in vivo immunosuppressive properties applicable for the control of graft-versus-host disease (GVHD). Stem Cells 2006; 24: 2582–2591.
  Article CAS Google Scholar
• Zhang J, Li Y, Chen J, Cui Y, Lu M, Elias SB et al. Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol 2005; 195: 16–26.
  Article CAS Google Scholar
• Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J et al. Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 2005; 52: 1595–1603.
  Article CAS Google Scholar
• Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, Lazarus HM . Rapid hematopoietic recovery after co-infusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307–316.
  Article CAS Google Scholar
• Lazarus HM, Curtin P, Devine S, Curtin P, Maziarz RT, Holland HK et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 2005; 11: 389–398.
  Article Google Scholar
• Frassoni F, Labopin M, Bacigalupo A, Gluckman E, Rocha V, Bruno B et al. Expanded mesenchymal stem cells (MSCs), co-infused with HLA identical hemopoietic stem cell transplants, reduce acute and chronic graft versus host disease: a matched pair analysis. Bone Marrow Transplant 2002; 29 (Suppl 2): S2.
  Google Scholar
• Koc ON, Peters C, Aubourg P, Raghavan S, Dyhouse S, DeGasperi R et al. Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp Hematol 1999; 27: 1675–1681.
  Article CAS Google Scholar
• Krivit W, Shapiro EG, Lockman LA, Koc ON, Lazarus HM . Bone marrow transplantation: treatment for globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy and Hurler syndrome. In: Moser HW, Vinken PJ, Bruyn GW (eds). Handbook of Clinical Neurology. Elsevier Science: Amsterdam, 1996, pp 87–106.
  Google Scholar
• Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W . Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant 2002; 30: 215–222.
  Article CAS Google Scholar
• Sillence DO, Rimoin DL, Danks DM . Clinical variability in osteogenesis imperfecta-variable expressivity or genetic heterogeneity. Birth Defects Orig Artic Ser 1979; 15: 113–129.
  CAS PubMed Google Scholar
• Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD et al. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood 2001; 97: 1227–1231.
  Article CAS Google Scholar
• Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932–8937.
  Article CAS Google Scholar
• Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F et al. Treatment of high risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 998; 339: 1186–1193.
  Article Google Scholar
• Handgretinger R, Lang P, Klingebiel T, Schumm M, Neu S, Geiselhart A et al. Megadose transplantation of purified peripheral blood CD34+ progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant 2001; 27: 777–831.
  Article CAS Google Scholar
• Passweg JR, Kuhne T, Gregor M, Favre G, Avoledo P, Tichelli A, Gratwohl A . Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplantation. Bone Marrow Transplant 2000; 26: 1033–1036.
  Article CAS Google Scholar
• Ball LM, Bernardo ME, Roleofs H, Lankester A, Cometa A, Egeler RM et al. Co-transplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haplo-identical hematopoietic stem cell transplantation. Blood 2007; 110: 2764–2767.
  Article CAS Google Scholar
• Broxmeyer HE . Introduction: The past, present and future of cord blood transplantation. In: Broxmeyer HE (ed). The Cellular Characteristics of Cord Blood and Cord Blood Transplantation. AABB press: Bethesda, Maryland, 1998, pp 1–9.
  Google Scholar
• Gluckman E, Broxmeyer HE, Auerbach AD, Friedman HS, Douglas GW, Devergie A et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from and HLA-identical sibling. N Engl J Med 1989; 321: 1174–1178.
  Article CAS Google Scholar
• Barker JN, Wagner JE . Umbilical cord blood transplantation: current state of the art. Curr Opin Oncol 2002; 14: 160–164.
  Article Google Scholar
• Barker JN, Krepski TP, DeFor TE, Davies SM, Wagner JE, Weisdorf DJ . Searching for unrelated donor hematopoietic stem cells availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 2002; 8: 257–260.
  Article Google Scholar
• Gluckman E, Rocha V, Chevret S . Results of unrelated umbilical cord blood transplant. Transfus Clin Biol 2001; 8: 146–154.
  Article CAS Google Scholar
• Rocha V, Wagner JE, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM et al. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 2000; 342: 1846–1854.
  Article CAS Google Scholar
• Locatelli F, Rocha V, Chastang C, Arcese W, Michel G, Abecasis M et al. Factors associated with outcome after cord blood transplantation in children with acute leukemia. Eurocord-Cord Blood Transplant Group. Blood 1999; 93: 3662–3671.
  CAS PubMed Google Scholar
• Rocha V, Cornish J, Sievers EL, Filipovich A, Locatelli F, Peters C et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 2001; 97: 2962–2971.
  Article CAS Google Scholar
• Barker JN, Weisdorf DJ, Defor TE, Blazar BR, McGlave PB, Miller JS et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 2005; 105: 1343–1347.
  Article CAS Google Scholar
• Bernardo ME, Ball LM, Cometa AM, Zecca M, Giorgiani G, Maccario R et al. Co transplantation of parental mesenchymal stem cells to improve outcome of cord blood transplantation in children. Bone Marrow Transplant 2006; 37: S1.
  Article Google Scholar
• Couriel A, Caldera H, Champlin R, Komanduri K . Acute graft versus host disease: pathophysiology, clinical manifestations, and management. Cancer 2004; 101: 1936–1946.
  Article Google Scholar
• Deeg HJ . How I treat refractory acute GVHD. Blood 2007; 109: 4119–4126.
  Article CAS Google Scholar
• Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O . Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439–1441.
  Article Google Scholar
• Le Blanc K, Frassoni F, Ball LM, Locatelli F, Roelofs H, Lewis I et al. Mesenchymal stem cells for treatment of severe, refractory acute graft-versus-host disease. Bone Marrow Transplant 2008; 41: S1–S215.
  Article Google Scholar
• Karlsson H, Samarasinghe S, Ball LM, Sundberg B, Lankester AC, Dazzi F et al. Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. Blood 2008; 112: 532–541.
  Article CAS Google Scholar
• Ringden O, Uzunel M, Sundberg B, Lönnies L, Nava S, Gustafsson J et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 2007; 21: 2271–2276.
  Article CAS Google Scholar